Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke

NCT01501773 is registered in ClinicalTrials.gov with Manipal Acunova Ltd. as lead sponsor.

NCT NCT01501773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01501773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke
Lead sponsor
Manipal Acunova Ltd.
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
October 31, 2011
Enrollment
120 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke